RecruitingNot Applicable

CAMpania PugliA bRanch Iliaco

Italy200 participantsStarted 2015-01-01

Plain-language summary

Spontaneus Multicentric Observational registry to investigate the medium and long-term performances of the Iliac E-liac Branch Device from Artivion for treatment of Aortoiliac aneurysms in a real-world consecutive patients cohort.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices Exclusion Criteria: * Patient's refusal to be enrolled in the registry * Patient treated with devices not including the E-liac stent-graft system

What they're measuring

Aneurysm related death

Timeframe: assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five years.

Procedure-related re intervention

Timeframe: assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five years

Trial details

NCT IDNCT06946381

SponsorFederico II University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-01

Contact for this trial

Umberto Marcello UM Bracale, PhD, Prof.

081 746 2629 chirurgiavascolarefedericoii@gmail.com

View on ClinicalTrials.gov More Aortoiliac Aneurysm trials